Robert Proulx

On July 13, 2001, the company entered into a merger agreement with PerkinElmer, Inc. Pursuant to the merger agreement, the company will become a subsidiary of PerkinElmer and each outstanding share of the company's common stock will be converted into 0.311 of a share of PerkinElmer common stock

Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland.

Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA

IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD.

Semrock, Inc. manufactures optical filters. It offers products for fluorescence instrumentation and microscopy, Raman instrumentation, and biomedical laser systems. The company was founded in September, 2000 by Victor Mizrahi and Turan Erdogan and is headquartered in Rochester, NY

Menarini-Silicon Biosystems SpA develops and distributes lab-on-a-chip technologies for miniaturized cell-biology testing. The company was founded by Nicol? Manaresi and Gianni Medoro and is headquartered in Castel Maggiore, Italy.

Senior Scientific was established in 1996, is concentrated in areas of consulting, instrumentation, and software design, in the physics of medical imaging. The Company utilizes a diverse aggregate of professional disciplines. Company facilities are located at the University of New Mexico Science and Technology Park, Albuquerque, New Mexico. Senior Scientific, LLC develops technology and theoretical modeling of bio magnetic fields and their medical and scientific applications. Focus is on the early detection of disease in humans through bio imaging methods using novel magnetic sensor systems and magnetic nanoparticles targeted towards specific diseases. Senior Scientific, LLC has extensive experience in design and application of very sensitive magnetic field detector systems, including measurement of magnetic fields from the brain (magnetoencephalography), heart (magnetocardiography), and from magnetized nanoparticles targeted to disease cells (relaxometry). Company research and development programs highlight new applications of these sensors in the field of cancer and other disease detection and localization. Major activities of Senior Scientific, LLC have been in the areas of software and hardware development in the region of weak magnetic field sensors and applications of the technology in antibody targeting of disease cells in-vitro and in-vivo. Recent research at Senior Scientific has been conducted in the area of a bio magnetic system for in vivo cancer imaging. Research in bio magnetic imaging, indicates that it is possible to detect and image small clusters of cancer cells in a rather novel method. The importance of these findings is that this method may substantially increase the sensitivity for detecting cancer at an earlier stage than is currently available and without the use of any ionizing radiation or large magnetic fields. Moreover, this approach also provides a location for the cancer which can be used as a guide either for the surgeon or for other methods of therapy. The effects of the treatment can then be monitored safely by further biomagnetic imaging. Other methods of therapy. The effects of the treatment can then be monitored safely by further biomagnetic imaging. In year 2009, Thomas J. Bowles, Scientific Advisor to Governor Bill Richardson of New Mexico and former chief science officer at the Los Alamos National laboratory, introduced Edward Flynn to Manhattan Scientifics Inc., a publicly traded company located in New Mexico dedicated to assisting scientific enterprises to commercialize disruptive technology. Dr. Flynn made the decision to commercialize his work and bring its benefits to humanity.

Pharmacogenetics Diagnostic Laboratory LLC provides pharmacogenomic testing and diagnostic information. It offers molecular diagnostic testing services, develops custom array profiles, and manages food and drug administration (FDA) clinical trials. The firm serves physicians, clinics and hospitals, contract research organizations, pharmacy and genetic benefits managers, and pharmaceutical companies. The company was founded by Roland Valdes, Jr. and Mark W. Linder in 2001 and is headquartered in Louisville, KY.

Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA.